Abstract Breast cancer remains a major global health burden and is characterized by substantial molecular and clinical heterogeneity. In recent years, considerable progress has bee
Loading
Source
2 developments in the corpus
Latest
Everything in the corpus, newest first.
Abstract Breast cancer remains a major global health burden and is characterized by substantial molecular and clinical heterogeneity. In recent years, considerable progress has bee
AUG 24, 2026 · JOURNAL ARTICLE
Hereditas
This is a mechanistic discovery study combining computational prediction, molecular profiling, and cell-based experiments that propose KIF11 as a target and NC as a candidate agent, but lacks clinical efficacy data, adequate in vivo validation, or direct evidence of NC's antitumor effect in animal models.